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INTRODUCTION
Cancers of head and neck refers to neoplasm arising from below the 
skull base to the region of thoracic inlet. They are diverse group of diseases 
each with distinct  epidemiologic,  anatomic  and pathologic features.  They 
show  wide  variation  in  natural  history,  prognosis  and  treatment 
considerations.
India is one of the high incidence zones for head and neck cancers. In 
India, the most common head and neck cancers are those of oral cavity and 
pharynx.  Age  adjusted  incidence  for  these  sites  in  Indian  population  as 
follows
Males  :    10.8 to  38.8/ 1 lakh  population                                 
Females  :  6 to  15/  1  lakh  population
Some tumor groups challenge routine histopathological classification 
of  Malignancies.  Because  of  the  absence  of  cell  morphological 
differentiation that characterizes their lymphoid, epithelial or mesenchymal 
origin. 
These  are poorly differentiated or undifferentiated tumors and can 
occur  with  relative  frequency  in  the  head  and  neck.  They  can  arise  in 
mucosa as well as in salivary  glands, soft tissues (or)  lymphnodes.
The  diagnosis  and  classification  of  such  tumors  are  fundamental 
because suitable therapy and prognosis for each case depends upon precise 
histopathological diagnosis. 
The introduction of the immunohistochemical method by Coons et al 
in 1942 has become a powerful complementary tool in tumor analysis. It has 
increased  the  possibilities  for  histogenetic  diagnosis  of  undifferentiated 
tumors.  Through the identification of specific cellular components of cell 
patterns, using a special panel of monoclonal or polyclonal antibodies, the 
immunohistochemical  method  has  transformed  the  diagnosis  of  these 
tumors.
        Diagnosis that used to be made on the basis of subjective information 
can now be accomplished using objective criteria. However there are only a 
few  references  in  the  literature  to  the  immunohistochemical  technique 
applied to the identification  of  undifferentiated  head and neck tumors.
                         
                                 
AIMS   OF   THE  STUDY
1.   To  know the distribution of tumors of head and neck with respect to 
the site of occurrence.
2.  Evaluation of undifferentiated head and neck tumors and the way in 
which they were distributed according to tumor location.
3. Undifferentiated head and neck tumor incidence according  to age and 
sex distribution.
4. To  evaluate  the  results  of  the  Immunohistochemical  techniques  in 
undifferentiated head and neck tumors.
5. To  analyse  the  usefulness  of  the  immunohistochemistry  in 
determining the conclusive diagnosis of undifferentiated tumors,  so 
that in the management of these tumors.
REVIEW     OF    LITERATURE
Malignant  Tumors  of the  Head  and  Neck
UNDIFFERENTIATED  TUMORS:
        Malignant neoplasm that composed  of undifferentiated cells are said to 
be anaplastic.  Lack  of differentiation is loss of the structural and functional 
differentiation of normal cells. Cancer arise from stem cells in tissues, so 
that failure of differentiation accounts for undifferentiated tumors.
     Anaplastic cells display marked pleomorphism hyperchromatic nuclei 
and large nuclei. Nuclear cytoplasmic ratio is 1:1 rather than 1:4 and 1:6. 
Anaplastic nuclei are variable and bizarre in size and shape. The chromatin 
is coarse and clumped. Mitosis is numerous and atypical. They loss normal 
polarity, grow in sheets with total loss of communal structures such as gland 
formation or stratified squamous architecture.
Because  of  the  absence  of  cell  morphological  differentiation,  it  is 
difficult and impossible to characterize these tumors according to their cell 
of  origin  into  lymphoid,  epithelial  or  Mesenchymal  origin  by  routine 
hematoxylin eosin staining technique.
These  undifferentiated  tumors  constitutes  10%  of  all  diagnosed 
tumors. In the head and neck, the undifferentiated tumor accounts for 3-6% 
with  the  exception  of  the  lymphnodes  most  frequent  locations  of 
undifferentiated tumors in the head and neck region is, pharynx, nose and 
paranasal sinuses.
           Immunohistochemistry is the application of immunologic principles 
and  techniques to the study of cells and tissues.
MALIGNANT TUMORS OF  NOSE AND PARANASAL SINUSES
      HISTOPATHOLOGICAL CLASSIFICATION
• Basal cell carcinoma
• Squamous cell carcinoma
• Tumors of minor salivary glands
• Sarcomas
• Malignant melanoma
• Esthesioneuroblastoma
• Lymphoreticular neoplasms
• Plasmocytoma
• Adenocarcinoma
• Undifferentiated carcinoma
• Malignant neurogenous tumors
Squamous  cell carcinoma:
• 50%  begin  in the maxillay antrum
• Every patient has signs of bony destruction when first seen
• Male preponderance
• Most cases the disease is localized
• Nasal vestibule tumors – indolent course – survival 80%
• Columella carcinoma   - most aggressive form of nasal tumor
• High recurrence rate
Adenocarcinoma:
• Uncommon tumor
• Common in people working in hardwood industry
• Histologically adenocarcinoma are best classified into high and low 
grade adenocarcinoma
Malignant melanoma:
• This comprises 1% of nasal and paranasal sinus cancers.
• Histologically, there is no relationship to clark’s skin classification
• Origin from the sinus mucosa is uncommon – if occurs survival is 0%, 
comparatively nasal melanoma has better response rate.
• Amelanotic melanoma quite frequently present as unilateral polyps, 
emphasizing  the  importance  of  sending  all  polypoidal  material  for 
pathological examination
• Biological behavior unpredictable
• Combination  chemotherapy  and immunotherapy  have  been used to 
treat melanomas.
Esthesioneuroblastoma    (olfactory neuroblastoma)
• This is a  neuroendocrine tumor, until recently rarely described- only 
400 cases reported.
• Resembles  an  anaplastic  carcinoma  and  may  remain  undiagnosed 
unless the pathologist uses special marker
• Tumor  arises  in  the  upper  part  of  nasal  cavity  from stem cells  of 
neural crest origin, which differentiate into  olfactory sensory cells.
• It is regarded as one of the primitive neuroectodermal tumors.
• Catecholamines can be demonstrated in olfactory neuroblastoma by 
fluorescent techniques after formaldehyde vapor (or) glyoxylic acid 
treatment.
• Biopsy  shows   nests  of  characteristic  cells  separated  into 
compartments with rosette formation
• Sometimes  tissue  produces  only  sheets  of  densely  packed  uniform 
round cells and is mistaken for undifferentiated carcinoma
• Differs from sympathetic neuroblstoma as all ages are affected
• This is a slow growing tumor which may become very large 
• Destructive and by its very nature must be regarded as involving the 
cribrifrom plate.
Tumors of minor salivary glands:
• The adenoid cystic carcinoma, muco epidermoid carcinoma can occur 
in the nasal sinuses.
• Vascular invasion, perineural invasion distant metastasis are frequent 
features.
Nasal neoplasms  -  Immunohistochemistry
Melanoma S-100, Vimentin; HMB45
Esthesioneuroblastoma Sustentacular pattern S-100
Lymphoma Common Leucocytic Antigen(CLA)
Cluster Differentiation(CD)
Muscle derived Muscle-specific actin/ desmin
Treatment policy of sinonasal malignancy:
• Surgery alone (or) in combination with radiotherapy is required in the 
majority of case
• Lymphomas are treated by grading and assessment of spread and then 
by radiotherapy and chemotherapy.
• Chemotherapy
 As part of triple therapy  
                    E g: embryonal rhabdomyosarcoma
            In combination with radiotherapy
                   Eg; disseminated lymphoma
          As palliation
                  Eg; Poorly differentiated squamous cell carcinoma with 
diseminated disease
• Surgery
             3 operations :
1. Lateral rhinotomy/Medial  maxillectomy
2. Total maxillectomy, 
3. Craniofacial resection
• Esthesioneuroblastoma
            This  is a radiosensitive tumour
           Craniofacial resection with radiotherapy
Malignant   Tumors of Nasopharynx
 Carcinoma of the nasopharynx is a leading cause  of death for large 
population in southeast asia
The age incidence curve is bimodal with a peak occurring between 15 
to 25 years , another  60 to 69 years cases showing familial aggression 
have been reported.
     The accumulated evidence strongly suggests that this tumour results 
from the combined action of  
- Genetic Predisposition  
- Environmental factors
- Epstein-Barr virus.
The  virus  can  be  demonstrated  in  the  tumor  tissue  with  insitu 
hybridization and immunohistochemical technique.
The virus has been found in all microscopic types of nasopharyngeal 
carcinoma including cases exhibiting glandular differentiation- although 
with different frequencies.
 TUMOR TYPES
Squamous cell carcinoma
Carcinoma  constitutes  85%  of  all   malignant  tumors  of  the 
nasopharynx. Nasopharyngeal carcinoma is divided into three types in the 
World Health Organisation(WHO) classification.
      All are regarded as varieties of squamous cell carcinoma. The three 
types are 
1. Keratinizing squamous cell carcinoma
                        Well differentiated
                   Moderately differentiatied
                   Poorly differentiated.
2. Non-keratinizing carcinoma which is undifferentiated.
3. Undifferentiated carcinoma of nasopharyngeal type.
           The nasopharyngeal carcinoma (formerly called transitional cell 
carcinoma,  lymphoepithelioma  or  lymphoepithelial  carcinoma)are  now 
regarded  as  falling  within  the  category  of  undifferentiated  carcinoma  of 
nasopharyngeal type.
THE  LYMPHOCYTE  INFILTRATE IN UNDIFFERENTIATED 
CARCINOMA CAN BE PREDOMINANT AND LEAD TO ERRORS IN 
DIAGNOSIS  UNLESS  IMMUNOHISTOCHEMICAL  TECHNIQUES 
WITH  LYMPHOCYTE  MARKERS  AND  ANTICYTOKERATIN 
ANTIBODIES  ARE  USED  TO  PREVENT  CONFUSION  WITH 
LYMPHOMAS.
It is impossible to say from where the tumor arise. Most of the tumors 
arising from   fossa of  rosenmuller
Other malignant tumors
- The second most common adult tumor is lymphoma. In  95%
         cases, it is non-Hodgkins lymphoma.
- Adenocarcinoma
- Adnoid cystic carcinoma
-  Plasmacytoma
- Multiple myeloma
- Malignant melanoma can rarely occurs in nasopharynx.
In  children  Rhabdomyosarcoma  is  the  commonest  malignancy   in 
nasopharynx and accounts for 30% of all malignancies in this site.
Treatment policy
The majority of patients are treated radically.
Radiation Therapy 
This is the primary treatment modality for nasopharyngeal carcinoma
Radiation  field  must  be  large  which includes  oropharynx,  retropharyngel 
node.
The  nasopharynx  is  a  midline  structure  with  bilateral  lymphatic 
drainage and so both sides of the neck should be treated even if only one 
side  has  detectable  lymphnodal  enlargement.  If  the  node  is  clinically 
involved, cervical node should be irradiated electively.
Chemotherapy
Often  with  platinum based  combination  is  being used  increasingly 
frequently in conjunction with radiotherapy for nasopharyngeal carcinoma.
Surgery   
          Has  minimal  role  that too  in  recurrent  tumors.
Immunohistochemical features
Immunohistochemically, nasopharyngeal carcinoma shows reactivity 
for  Keratin(always),  epithelial  membrane  antigen  (usually), 
CEA(occasionally).
Thus keratin is the most  reliable marker for  identification  of this 
neoplasm. A population of S-100 protein positive dendritic cells may also be 
present.
Malignant tumors of the  Oropharynx
- The  oropharynx  is  lined  by  squamous  epithelium,  so  squamous 
carcinoma represents the most common tumor
- There is abundant lymphoid tissues in the palatine tonsil and also the 
lingual tonsil which can be affected in the head and neck lymphoma
- The soft  palate  is  especially  rich in  minor  salivary glands – minor 
salivary gland tumors can occur.
  Tumor types
     -    Squamous cell carcinoma-commonest malignancy     - 90%
     -    Non-hodgkins   lymphoma                                           -  8%
     -    Minor salivary gland tumor                                           -  2%
     Prognostic factors
- General condition/age
- TNM  status
- Histology of the tumor
- Vascular/perineural  invasion
Tumor Spread
Lateral wall tumors (Tonsil)
These are the commoner, often involves tonsil spread to retromolar 
trigone, to buccal mucosa, into the muscles of tonguebase. If erode deeply, 
they involve pterygoid muscles producing trismus. Inferiorly to the lateral 
pharyngeal  wall,  pyriform  sinus,  inferomedially  to  aryepiglottic  fold, 
paraglottic space and posteriorly to the posterior pharyngeal wall.
Base of tongue tumors
- Symptoms present only in the advanced stage
- Rapidly spreads through genioglossus muscle and across the midline, 
very quickly involve the entire tongue
- Spreads  inferiorly  into  vallecula,  the  epiglottis  and  hence  into  the 
supraglottis and  preepiglottic space.
Soft palate tumors
almost   exclusively  appears  on  anterior  surface  spreads  to 
nasopharynx, superior pole of the tonsil.
Treatment policy
Treatment options: squamous carcinoma
        Curative:
                         Radiotherapy
                        Surgery
                        Surgery and post operative radiotherapy
       Palliation:
               Radiotherapy
                Radiotherapy/chemotherapy
               Tracheostomy
Inoperability of oropharyngeal squamous cell carcinoma
          Poor general condition
          Disease involving nasopharynx, tongue, larynx, direct neck extension.
          Distant metastasis
          Second primary
Lymphoma:
         Once the diagnosis of lymphoma was made,the disease should be 
staged and treatment may be with either chemotherapy (or) radiotherapy (or) 
combined modality of treatment. Most recurrences, if occurs, occur within 
18 months. If there is a recurrence . the patient has only 10% chance of long 
time survival.
Malignant tumors of the  Hypopharynx
- Hypopharynx represents  the lower most part of the pharynx
- Divided into 3 distinct sites
- Posterior pharyngeal wall – 10%
- The pyriform sinus             – 55%
- The post cricoid space        – 35%
Squamous cell carcinoma
- Piriform sinus may involve lateral wall (or) medial wall -marginal  
- More extensive, than they appear at clinical examination.
- Post cricoid  tumor shows submucosal extension
- Maximal mural extension is medially 25mm and downward-20mm
- Lymphnodal metastasis  more at presentation is seen in post cricoid 
and posterior pharyngeal wall tumors.
Other malignant tumors
- Pseudosarcoma (or) spindle cell carcinoma,
-  Plasmocytoma,
     -    Leiomyosarcoma,
     -   Adenoid cystic carcinoma
Lymphoma
Some tumors which are not exclusively in the province of the head 
and neck surgeon and can occur in many other parts of the body, includes 
various types of lymphoma .
When they present with head and neck symptoms and signs, the head 
neck surgeon plays a pivotal role in obtaining tissue for diagnosis and in the 
treatment .
The lymphoid malignancy divided into
- Hodgkin’s disease
- Non-Hodgkin’s lymphoma
Malignant  lymphoma  can  present  initially  as  a  mass  in  the  sinonasal 
region, Nasopharynx, Tonsil. Nearly all cases are of Non.Hodgkin type. The 
large majority fall in three categories
- Natural killer (NK) /T-cell type
- B-cell type
- Peripheral Tcell type
NK /T-cell lymphoma
This is a recently delineated distinct clinicopathologic entity which is 
highly  associated  with   Epstein-Barr   virus.   Morphologically,  it  is 
characterized  by  a  broad  cytologic  spectrum  ranging  from  small  or 
medium  sized  to  large  transformed  cells.  Necrosis  is  nearly  always 
present. 
Angioinvasion by tumor cells is  a very frequent and diagnostically 
important  feature  and  this  is  sometimes  accompanied    by 
epitherliotropism  reminiscent  of  that  seen  in  mycosis  fungoides.  An 
admixture of reactive histocytes some exhibiting erythrophagocytosis is a 
frequent  feature,  probably  representing  as  expression  of  the  virus-
associated hemophagocytic syndrome. This type of lymphoma is referred 
to as angiocentric lymphoma.
The  immunophenotype  of  NK/  T-cell  lymphoma  is  characteristic. 
Positive  for  CD2  and  CD56  and  usually  negative  for  surface  CD3. 
Cytoplasmic CD3  can be detected in paraffin sections. There is no clonal 
rearrangement  of  the  T-cell  receptor  gene.  Tumors  with  similar 
phenotype occurring at  other  extranodal  sites  referred to as  nasal  type 
NK/T-cell  lymphoma  (in  skin,  GIT)  Blastois,  Leukemic  forms  of  this 
lymphoma occur. CD56 positivity is a key diagnostic feature. This can be 
also seen in non-lymphoid  neoplasmus eg., Ewings sarcoma.
High  percentage  of  cases  of  lethal  midline  granuloma  are  due  to 
NK/T-cell lymphoma.
B-cell Lymphoma
B-cell lymphoma  of the sinonasal region usually presents in a large 
cell  lymphoma  with  a  diffuse  pattern  of  growth  and  a  relatively 
monomorphic appearance. It is much more common in paranasal sinuses 
than in the nasal cavity. It constitutes the most common site of sinonasal 
lymphoma.
     B-cell lymphoma with a diffuse undifferentiated appearance are the 
predominant form of sinonasal lymphoma in the pediatric population. 
Peripheral Tcell lymphoma
Peripheral  Tcell  does  not  express  CD56  and  usually  lacks  the 
necrotizing  and  angiocentric  features  of  NK/Tcell  lymphoma.  The 
behavior of sinonasal lymphoma is difficult to assess because of the fact 
that one of its major types has been only recently defined, that some of 
the  reported  series  do  not  include  a  thorough  immune  phenotypic 
evaluation and that many cases of NK/Tcell lymphoma go unrecognized 
for  years.70-80%  of  patients  with  Tcell  lymphoma  shows  complete 
response rate of 75%. In case of B cell lymphoma overall survival rate is 
52%.
Plasmacytoma
           Arising in the nasal cavity (or) nasopharynx may present primarily 
in the nose as a soft bleeding  mass. microscopic examination shows a 
monomorphic infiltration by immature plasma cells. The majority of the 
patients  with  apparently  solitary  plasma  cell  tumors  of  the  upper  air 
passages  in  whom  there  is  adequate  follow  up  develop  disseminated 
myeloma.  Local  control  of  disease  usually  be  achieved with radiation 
therapy. 
Angiotropic lymphoma
      In this conditioin the neoplastc lymphocytes are predominantly within 
the  lumen  of  the  vessels  rather  than  infiltrating  the  vessel  wall.  This 
unusual type of lymphoma can present initially as an intranasal lesion.
Pseudolymphoma
         Lymphoid hyperplasia present as polypoidal intranasal mass.
Hodgkin’s disease
This  is   very  rarely  affects  the  head  and  neck  region  isolated 
occurence  reported.  Peak  age  distribution  is  bimodal.  20  to  30  years 
one peak.    another  peak  at  old age.
       Association with Epstein-Barr virus noted in some cases.
Histopathology
The  typical  lymphnode  architecture  is  affected  by  a  mixture 
comprising  predominantly  normal  cells  and  a  lesser  proportion  of 
abnormal  lymphoid  cells.  The  normal  cells  –  lymphocytes,  histocytes, 
eosinophils,  plasmacells  and the malignant  population  Reed-sternberg 
cells, its mononuclear variant called Hodgkin cell.
Reed-sternberg  cell:  Large  cell  with  eosinophilic  cytoplasma.  It 
contains 2,  sometimes  4 (or)  more  mirror-image lobulated nuclei  with 
darkly staining nuclear membrane.
B symptoms in Hodgkin’s disease
 Fever,     Weight loss,     Night sweats
The Revised European-American Lymphoma (REAL) classification
B-cell neoplasm
I- Precursor B-cell neoplasm
1. Precursor B-lymphoblastic lymphoma
    II – Peripheral B-cell Neoplasms.
1. B  cell  chronic  lymphocytic  leukemia/  small  lymphocytic 
lymphoma.
2. Lymphoplasmacytoid  lymphoma
3. Mantle cell lymphoma
4. Follicular lymphoma grade I, II, III
5. Marginal zone B-cell lymphoma
.Extranodal  ,     . nodal
6. Splenic marginal zone lymphoma
7. Hairy cell leukemia
8. Plasma cytoma/myeloma
9. Diffuse large B cell lymphoma
10. Burkitt’s lymphoma
11.High grade B-cell lymphoma, Burkitt like.
Tcell  and postulated natural killer cell (NK) neoplasm
I  .  Precursor Tcell neoplasm
1.Precursor T-lymphoblastic lymphoma
II .  Peripheral T cell and postulated NK cell neoplasm
1.  T cell chronic lymphatic leukemia/ lymphoma
2. Large granular cell lymphatic leukemia
. T  cell type / natural killer cell type
3. Mycosis fungoides/ sezary syndrome
4. Peripheral T cell lymphoma unspecified
5. Angioimmunoblastic T cell lymphoma
6. Angiocentric lymphoma
7. Intestinal T cell lymphoma
8. Adult T cell lymphoma (HTLV-I)
9.  Anaplastic large cell lymphoma(T and NK cell type)
10.Anaplastic large cell lymphoma Hodgkin’s like.
Murphy staging system for Non-Hodgkin’s lymphoma
Stage                                          Definition
I                     A single tumor(extranodal) (or) single anatomical    area   
        (nodal) with the exclusion of the mediastinum or abdomen.
      II                  A single tumor with regional node involvement
 Two or more nodal areas on the same side of diaphragm
 Two  single  tumors  with/without  regional  node 
involvement    
 On the same side of the diaphragm
     III                    Two single tumors on opposite side of the diaphragm
 Two or more nodal areas above and below diaphragm
 All primary intrathoracic tumor (pleural, Thymic)
 All primary intraabdominal disease
    IV                  Any of the above with initial CNS/ bone marrow 
                           Involvement.
Rye’s classification of Hodgkin’s disease
1.  Lymphocyte predominant  (rare)                     - Nodular,Diffuse
2.  Nodular sclerosing             (commonent type) –Type I and II
3. Mixed cellularity                 (less common)
4. Lymphocyte depleted          (rare)
Ann Arbor  staging classification
Stage                                 Definition
 I                 involvement of single extranodal site (or) single nodal 
                    Region such as spleen, waldeyer’s ring
II                2 or more lymph node region/lymphatic structure on the         
                  Same side of diaphragm
                  Localized involvement of an  extranodal organs or site  and
                 Of one or more lymphnode regions on same side of 
                 Diaphragm
III              Involvement of lymphnode region/structures on both 
                  Sides of diaphragm
IV             Diffuse or disseminated involvement of one or more 
                Extranodal organs/ tissues with or without associated
                Lymphnode involvement
A or B       A- Absence       B- presence of constitutional symptoms
o More than 10%  weight loss in 6 months
o Unexplained fever during previous month
o Recurrent night sweat during previous month
    Treatment  policy
 Tumor  characterized,  classified  and  staged-  the  patient’s  age, 
performance  status,  comorbidity  ,  also  should  be  taken  into 
consideration.
 Localized stage I low grade follicular NHL may be cured by 
          Involved field radical radiotherapy. 
 Even  extensive  disease  has  better  cure  rate.  Simple  chemotherapy 
with oral chlorambusil & prednisolone may be all that is required.
 The  initial  treatment  for  fit  patients  with  high  grade  lymphoma 
nowadays usually chemotherapy and about half of adult patients may 
be cured.
 In children the cure rate is close to three quarters.
 The  standard  regimen  CHOP –  cyclophosphamide,  doxorubicin, 
vincristine, prednisolone
 For patients with localized disease especially in the head and neck, 
this is followed by radio therapy.
IMMUNOHISTOCHEMISTRY
Immunohistochemistry  or  Immunocytochemistry (IHC) is  a method 
for localizing specific antigens in tissues or cells based on antigen-antibody 
recognition; it seeks to exploit the specificity provided by the binding of the 
antibody with its antigen at the microscopic level. IHC has a long history, 
extending more than half a century from 1940 when Coons developed an 
immunoflourescence technique to detect  corresponding antigens in frozen 
sections.
 However only since the early 1990s has the method found general 
application in surgical pathology. A series of technical developments in IHC 
have  created  sensitive  detection  systems.  Among  them is  the  enzymatic 
label (Horse  radish  peroxidase)  developed  by  Avrameas  and  colleagues 
which in the presence of a suitable colorogenic substrate systems, allowed 
visualization of the labeled antibody by orthodox light microscopy. 
One of the critical issues in the development of immunoperoxidase 
techniques was related to the need to achieve greater sensitivity from the 
simplest one step direct conjugate method to multistep detection techniques 
such as the Peroxidase-Antiperoxidase, avidin-biotin conjugate and Biotin 
streptavidin  methods,  together  with  amplification  methods  and  highly 
sensitive polymer based labeling systems .
The  development  of  hybridoma  technique facilitated  the 
development  of  IHC  and  the  manufacture  of  abundant  highly  specific 
monoclonal antibodies, many of which found early application in staining of 
tissues. Only when the IHC became applicable to routinely formalin fixed, 
paraffin embedded tissue sections did it  usher in the “brown revolution”. 
The critical significance of rendering the IHC technique suitable for routine 
paraffin  sections  was illustrated  by Taylor  and colleagues,  who in  1974, 
showed that it was possible to demonstrate antigens in routinely processed 
tissue . 
Enzyme  digestion was  introduced  by  Huang  and  colleagues  as  a 
pretreatment to IHC staining to unmask some antigens that had been altered 
by formalin fixation. However the enzyme digestion method, while widely 
applied did not improve IHC staining of the majority of antigens as reviewed 
by Leong and colleagues. Another drawback of enzyme digestion was that it 
proved difficult to control the optimal “digestion” conditions for individual 
tissue sections when stained with different antibodies. These difficulties in 
standardization provided a powerful incentive for the development of a new 
technique.
The  antigen  retrieval (AR)  technique  was  developed  by  Shi  and 
associates in 1991. In contrast to enzyme digestion the AR technique is a 
simple method that involves heating routinely processed paraffin sections at 
high temperatures before IHC staining procedures.  An alternative method 
that did not use heating was developed for celloidin-embedded tissues. The 
intensity of IHC staining was increased dramatically after AR pretreatment, 
as demonstrated by various articles. 
BASIC PRINCIPLES OF IMMUNOHISTOCHEMISTRY
The object of all stains is to recognize micro chemically the existence 
and distribution of substances which we have been made aware of macro 
chemically. The basic principle of IHC as with any other special staining 
method is a sharp localization of target components in the cell and tissue 
based  on  a  significant  signal-to-noise  ratio.  Amplifying  the  signal  while 
reducing the nonspecific background staining (noise) is the major strategy to 
achieve a satisfactory and practically useful result.
An  antibody is  a  molecule  that  has  the  property  of  combining 
specifically with a second molecule, termed the antigen. Antigen-antibody 
recognition is based on three dimensional  structure of protein or antigen, 
which is a critical issue in the understanding of the effectiveness of IHC as 
well as the mechanisms of AR. The term epitope corresponds to a cluster of 
amino acids residues that bind specifically to the paratope of an antibody. 
An epitope is a functional unit and not structural element of a protein and 
may  be  classified  as  continuous  and  discontinuous.  The  former  are 
composed, of a continuum of residues in a polypeptide chain, whereas the 
latter consist of residues from different parts of a polypeptide chain, brought 
together by the folding of the protein conformation.
The  development  of  hybridoma  technique  provided  an  almost 
limitless  source  of  highly  specific  antibodies.  Although  monoclonal 
antibodies do not guarantee antigen specificity, since different antigens may 
share similar or cross reactive epitopes, the practical specificity reflected by 
IHC is excellent for most monoclonal antibodies tested. In contrast a poly 
clonal  antibody  is  infact  an  antiserum,  which  contains  several  different 
molecular  species of  antibody having varying affinities  and even varying 
specificities  against  the different  antigens or  antigenic determinants  As a 
result polyclonal antibodies may give more nonspecific background staining 
in slides than the staining obtained using monoclonal antibodies.
Comparison  of  sensitivity  and  specificity  between  polyclonal  and 
monoclonal  antibodies  indicate  that  polyclonal  antibody  may  be  more 
sensitive but less specific than monoclonal antibody. The reason may be that 
polyclonal  antibody may recognize  several  different  epitopes on a  single 
antigen whereas a monoclonal antibody recognizes only a single type of 
epitope. Sophisticated amplification techniques, coupled with use of the AR 
technique  have  reduced  the  practical  importance  of  this  distinction. 
Although  the  specificity  of  monoclonal  antibody  has  been  questioned 
regarding  cross  reactivity  with  non-target  molecules,  most  commercially 
available monoclonal antibodies are highly reliable for IHC, but again the 
ultimate specificity control should be the observation of the expected pattern 
of  staining  in  control  tissue  sections,  with  the  corresponding  lack  of 
unexpected or inexplicable staining reactions .
BLOCKING NON-SPECIFIC BACKGROUND STAINING
There  are  two  aspects  to  the  blocking  of  background  staining  of 
tissues,  nonspecific  antibody  binding  and  the  presence  of  endogenous 
enzymes. Non specific antibody binding is generally more of a problem with 
polyclonal  antibody,  because  multiple  unwanted  antibodies  may  exist  in 
antiserum.  The  greater  the  optimal  working  dilution,  the  smaller  the 
problem. If necessary it is advisable to pre incubate the tissue sections with 
normal serum from the same species of animal in order to occupy unwanted 
binding sites before incubation with primary antibody.
If enzymes similar to those used as a tracer are present in the tissue 
they may react with the substrate used to localize the tracer and give rise to 
problems in interpretation. Inhibiting the endogenous enzymes activity prior 
to  staining  can  eliminate  false  positive  reactions  produced  in  this  way. 
Peroxidase and substances giving a pseudo peroxidase reaction are present 
in  normal  and  neoplastic  tissues,  e.g.   leucocytes  and  erythrocytes  and 
various methods have been described for the destruction of their activity.
                    Incubation in absolute methanol containing 0.5 percent 
hydrogen peroxide for 10 minutes at room temperature has been reported to 
produce  an  almost  complete  abolition  of  endogenous  peroxidase  activity 
without affecting the immunoreactivity of antigens. 
There are many types of alkaline phosphatase within the human body 
and most endogenous alkaline phosphatase activity can be blocked using a 
1mM concentration of levamisole in the final incubating medium. The other 
commonly  used  enzyme  labels  glucose  oxidase  and  bacterial  beta-2-
galactosidase do not present a problem.
IMMUNOCYTOCHEMICAL METHODS
Traditional Direct Technique
The  primary  antibody  is  conjugated  directly  to  the  labels.  The 
advantage of the directly labeled antibody is that they are simple to use as 
they  only  require  only  one  application  of  the  reagent,  followed  by 
appropriate  chromogen  substrate  solution.  The  disadvantage  is  that  the 
sensitivity when compared to 2 or 3 stage techniques is low. While the most 
popular direct conjugates are those which are labeled with Fluorochrome. 
Horse radish peroxidase and alkaline phosphatase directly labeled antibodies 
are occasionally used.
New Direct Technique: (Enhanced Polymer one-step staining method)
A  large  number  of  primary  antibody  molecules  and  peroxidase 
enzymes are attached to a dextran polymer backbone. The advantages of this 
technique are  it is rapid, especially frozen sections immunohistochemistry 
and sensitive enough to demonstrate small amount of antigen.
Indirect Techniques:-
The unconjugated primary antibody is applied, followed by a labeled 
antibody directed against the first antibody. Horse radish peroxidase labeling 
is most commonly used and with appropriate chromogen substrate is a more 
sensitive technique than the equivalent direct method.
Avidin-Biotin Techniques
These methods rely on the marked affinity of the glycoprotein avidin 
for biotin, a low molecular weight vitamin. Avidin is present in egg white 
and is composed of four subunits which form a tertiary structure possessing 
biotin binding hydrophobic pockets. The oligosaccharide residues present in 
egg white avidin and its charged properties are reported as giving it some 
affinity for some tissue components and the result is non specific binding. 
Also some tissues such as liver contain large amounts of biotin and this can 
cause further background problems. A similar molecule streptavidin can be 
extracted from the culture broth of the bacterium Streptomyces avidini. The 
lack of oligosaccharide residues and neutral isoelectric point is said to give 
streptravidin advantages over the chicken egg variant.
Biotin (vit H) is easily conjugated to antibodies and enzyme markers. 
Up to 150 biotin molecules can be attached to one antibody molecule, often 
with the aid of spacer arms. By spacing the biotins, the larger glycoprotein 
avidin has room to bind and maximize its strong affinity for biotin.
Variants  of  avidin-biotin  system  include  peroxidase  and  alkaline 
phosphatase either directly bound to avidin or streptavidin. Alternatively the 
enzymes are biotinylated and 75% of avidin-binding sites are occupied by 
the biotinylated label forming the avidin-biotin complex. .
Hapten Labeling Technique:-
Bridging techniques using haptens such as dinitirophenol and arsenilic 
acid have been advocated.(13) In this technique the hapten is linked to the 
primary antibody and a complex is built up using an anti-hapten antibody 
and either hapten-labeled enzyme or hapten labeled PAP complex.
Immuno Gold silver staining Technique (IGSS)
The use of colloidal  gold as a label  for immunocytochemistry was 
introduced by Faulk and Taylor. It can be used in both direct and indirect 
methods and has found wide usage in ulltrastructural immunolocalisation. It 
is  not widely used in light  microscope IHC even after  the advantages of 
silver development reported by Holgate et al in 1983 (14). In this method the 
gold  particles  are  enhanced  by  the  addition  of  metallic  silver  layers.  To 
produce slow forming metallic silver with a tolerance for natural light, the 
technique uses silver  lactate  as the ion supplier  and hydroquinone as the 
reducing agent in a protective colloid of gum Arabic at PH 3.5. The method 
is generally accepted to be more sensitive than the PAP technique but suffers 
from the formation of  fine silver  deposits  in the background and can be 
confusing when trying to identify small amounts of antigen.
Antigen Retrieval
A  simple  heat  induced  AR  technique  is  now  widely  applied  in 
pathology.  Successful  application  of  the  AR  technique  for  routine  IHC 
staining of  formalin fixed tissues has rendered the search for  alternative 
fixatives to replace formalin less urgent.
Heat mediated Ag Retrieval – Commonly employed antigen retrieval 
methods include microwave oven, pressure cooker, steamer, autoclave.
               
MATERIALS    AND    METHODS
   A  study  was  made  of  30  biopsies performed  from the  period  of 
April  2006 to  march  2007  from the  head  and neck  regions  in  the  ENT 
department,   Upgraded Institute of Otorhinolaryngology, Madras Medical 
College,  Chennai  –  Histopathologically  that  were  diagnosed  as 
undifferentiated tumors.
    Type  of   study
                Prospective  study
     Period  of  study
               April-2006  to  March-2007
 The Inclusion critieria 
• Tumors located in the head and the neck
• Histopathological diagnosis of undifferentiated tumors   in sections 
stained using hematoxylin – Eosin (HE)
• Sufficient  quantity  of  material  in  the  paraffin  section  for 
Immunohistochemical technique to be performed.
  The  Exclusion   criteria
• Tumors  with  evident  differentiation  seen  in  sections  strained 
using  HE
• Specimens  with  insufficient  material  for  the 
immunohistochemical technique
• Tumors affecting the skin of head and neck region
• Secondary  necknodes  with  unknown  primary   lymphnode 
biopsies.
All the biopsies utilized were fixed in formalin 10%, embedded in 
paraffin  and  stained  with  hematoxylin  –  eosin  (HE).  They  all  had  a 
diagnosis of undifferentiated tumors as seen under optical microscopy.
These tumors are distributed according to their site of occurrence, into 
8  groups,  oral  cavity,  oropharynx,  nasopharynx,  hypopharynx,  larynx, 
nose, paranasal sinuses, others.
These  biopsies  applied  to  an  immunohistochemical  panel  with 
monoclonal  antibodies.In  accordance  with  the  avidin-biotin  peroxidase 
complex method (ABC) and with respect to the patient’s age and tumor 
location.
IMMUNOHISTOCHEMICAL   PANELS   EMPLOYED
Epithelial                           Cytokeratin
Lymphoid                           CD -    3
                                            CD -  20
                                            CD -  45
    Mesenchymal                     S   - 100 protein
IMMUNOCYTOCHEMICAL STAINING  TECHNIQUES
Washes
Between each step, sections require washing to prevent one reagent 
contaminating  another.  Gently  wash  with  Tris  bufferd  Saline  (TBS) 
indicates several brief washes flooding the slide, followed by draining and 
wiping around the section to remove excess buffer.
Buffer
0.005M  Tris-buffered saline 
 Distilled water                                            10 liters
Sodium chloride                                          80.0g
TRIS (hydroxymethyl methylamine)           6.05g
M HCL                                                           44 ml
If  necessary,  adjust  final  pH to 7.6  with either  1M HCL or  0.2M TRIS 
solution.
After the appropriate pretreatment steps, the following method employed
Avidin-biotin Technique
       In these techniques eithr peroxidase or alkaline phosphatase may be 
used as the enzyme label.
Labelled avidin/avidin-biotn complex technique for monoclonal antibodies
Method
1.   Bring sections to TBS.
2. Drain and wipe off excess TBS around section]
3. Incubate in optimally diluted primary antibody for 30-40min
4. Gently wash slides with TBS
5. Incubate in optimally diluted biotinylated bridge reagent for 30min
6. Repeat step 4
7. Incubate in optimally prepared  labeled avidin/avidin-biotin complex 
for 30min.
8. Repeat step 4
9. Incubate in DAB substrate solution
10.Wash in running water, counterstain in hematoxylin, dehydrate clear 
and mount.
The  final  diagnosis  was  achieved  after  new  microscopic 
analysis in conjunction with sections stained using the hematoxylin –
Eosin Technique. The results were distributed according to patients 
age, tumor location
RESULTS  AND  ANALYSIS
The following are the results and analysis after a study of 30 
biopsies  of  undifferentiated  tumors  and  the  application  of 
Immunohistochemical techniques.
AGE AND SEX DISTRIBUTION
          Age  incidence  and  sex  distribution  of  the  patients  with 
undifferentiated head  and neck cancer was tabulated and analysed.
                                         TABLE – I
Age 
incidence
Sex
Total PercentageMale Female
20> 1 3 4 13.3%
21 to 30 2 1 3 10%
31to 40 - 2 2 6.5%
41 to 50 5 2 7 23.33%
51 to 60 3 2 5 16.67%
> 61 9 - 9 30%
Total 20 10 30 100%
UNDIFFERENTIATED  HEAD AND NECK CANCERS
AGE   INCIDENCE
   
         
UNDIFFERENTIATED  HEAD AND NECK CANCERS
AGE   DISTRIBUTION
UNDIFFERENTIATED  HEAD AND NECK CANCERS
SEX  INCIDENCE
BERNARD INSTITUTE  OF RADIOLOGY  AND ONCOLOGY 
STATISTICS
Head and Neck Male Female Total
Lip 4 4 8
Alveolus 18 9 27
Tongue 70 29 99
Floor of mouth 16 4 20
Cheek 64 68 132
Palate 25 7 32
Salivary gland 14 10 24
Oropharynx 82 31 113
Nasopharynx 18 8 26
Laryngopharynx 87 59 146
Larynx 88 30 118
Ear 4 1 5
Nasal cavity 13 8 21
Paranasal sinuses 12 7 19
Other sites 32 19 51
Total 547 284 841
    Among Head and neck tumors , undifferentiated tumor constitutes 3.57% , 
where males constitute 3.66% and females 3.52%    
                             
SITE   OF   OCCURRENCE
CLINICAL   CLASSIFICATION   OF  PATIENTS
TABLE - III
SITE Male Female Total Percentage
Oral cavity 1 2 3 10
Oropharynx 7 0 7 23
Nasopharynx 3 3 6 20
Hypopharynx 2 2 4 13
Larynx 1 1 2 6.5
Nose 1 2 3 10
Paranasal 
Sinuses
3 - 3 10
Others 2 - 2 6.5
Total 20 10 30
• Pharynx  constitutes  56%  of  those,  Oropharynx  23%  which 
suggests  The  overall  incidence  of  oropharyngeal  tumor  is  high 
rather  than  its  higher  percentage.  Because  the  percentage  of 
undifferentiated  oropharyngeal  tumor  compared  with  other 
oropharyngeal tumor is 6.19%.
PROPORTION OF UNDIFFERENTIATED  TUMORS OF  HEAD 
AND NECK
TABLE - IV
LOCATION CANCER
UNDIFFERENTIATED
CANCER
PERCENTAGE
Oral cavity 179 3 1.68%
Oropharynx 113 7 6.19%
Nasopharynx 26 6 23.08%
Hypopharynx 146 4 2.74%
Larynx 118 2 1.69%
Nose 21 3 14.29%
Paranasal 
sinus
19 3 15.79%
• Naso pharynx has highest proportion of undifferentiated tumor . 
that is 23%
IMMUNOHISTOCHEMISTRY  RESULTS
TABLE - V
Tumor
Location
Carcinoma Lymphoma Others Inconclusive Total
Oral cavity 3 - - - 3
Oropharynx 2 2 - 3 7
Nasopharynx 2 2 2 - 6
Hypopharynx 3 - - 1 4
Larynx - 1 - 1 2
Nose 1 1 1 - 3
Paranasal 
sinus
2 1 - - 3
Others - - 1 1 2
Total 13 7 4 6 30
• In  case  of  nasal  cavity,  S-100 positive  olfactory  neuroblastoma 
diagnosed.
• More  numbers  of  lymphoma  diagnosed  in  Oropharynx  and 
Nasopharynx , 2 each.
TUMOR TYPES IN ACCORDANCE WITH
AGE OF PATIENTS
TABLE - VI
AGE Carcinoma Lymphoma Others Inconclusive Total
20> 1 2 1 - 4
21 to 30 1 2 - - 3
31to 40 1 - - 1 2
41 to 50 2 1 2 2 7
51 to 60 1 1 1 2 5
> 61 7 1 - 1 9
Total 13 7 4 6 30
• In younger age – Lymphoma is the dominant group.
• For above 60 years of age – carcinoma is the dominant type
PERCENTAGE   OF  TUMOR   TYPES
TABLE   VII
Type of Tumors No. of cases Percentage
Carcinoma 13 43.33  %
Lymphoma 7 23.33  %
Others 4 13.33  %
Inconclusive 6 20  %
• Carcinoma  is the major group followed by lymphoma
• Either conclusive or suggestive diagnosis of undifferentiated  tumor 
was achieved on this study is 80%
• Inconclusive  diagnosis  –  that  is  not  positive  for  any  of  the 
immunohistochemical  panel  (or)  positive  for  carcinoma,  lymphoma 
and mesenchymal markers, because of multiple epitopes is the main 
cause in this study.
PERCENTAGE   OF  TUMOR   TYPES

IMMUNOHISTOCHEMICAL MARKER POSITIVITY WITH 
RELEVANCE TO TUMOR LOCATION
TABLE VIII
Tumor 
location
CK CD3 CD20 CD45 S-100
Oral Cavity 4 - - - 1
Oropharynx 2 - 2 2 -
Nasopharynx 4 - 3 3 -
Hypopharynx 3 - - - -
Larynx - 1 - 1 -
Nose 1 - 1 1 1
Paranasal 
sinus
2 1 - - -
Others 2 - 2 - 1
Total 18 2 8 7 3
• Cytokeratin is indicative of the carcinoma 
• CD20,  CD45 positivity  indicates  the lymphoma which is  of  B-cell 
variety.
• CD3  positivity  indicates  T  cell  lymphoma  (or)  natural  killer  cell 
lymphoma
CONCLUSIVE   DIAGNOSIS    BY 
IMMUNOHISTOCHEMICAL TECHNIQUES    ACCORDING 
TO   TUMOR   LOCATION
TABLE IX
Location Conclusive Inconclusive Total
Conclusive 
percentage
Oral Cavity 3 - 3 100%
Oropharynx 4 3 7 57.14%
Nasopharynx 6 - 6 100%
Hypopharynx 3 1 4 75%
Larynx 1 1 2 50%
Nose 3 - 3 100%
Paranasal 
sinus
3 - 3 100%
Others 1 1 2 50%
• 100%   conclusive diagnosis  was achieved in cases  of  oral  cavity, 
Nasopharynx, nose and paranasal sinuses in this study
• In Larynx and oropharynx, the percentage of conclusive diagnosis is 
around 50%
      DISCUSSION
The  poorly  differentiated  (or)  undifferentiated  tumors  challenge 
routine  histopathological  classification,  because  of  the  absence  of  cell 
morphological  differentiation.  The  diagnosis  and  classification  of  such 
tumors are fundamental, because suuitable therapy and  prognosis for each 
case depends upon precise hisopathological diagnosis.
The  immunohistochemical  technique  has  revolutionized  surgical 
pathology knowledge.  The introduction of  this  method by coons et  al  in 
1942 has become a powerful complementary tool in tumor analysis.
There  are  only  few  references  in  the  literature  to  the 
immunohistochemical  technique  applied  to  the  identification 
of   undifferentiated  head and neck tumors.
Undifferentiated cancer incidence
Head and neck tumors constitutes about 35% of all diagnosed cancers
Undifferentiated  tumors  in  the  head  and  neck  represents  3.57% of  all 
tumors diagnosed in this study (30 cases out of 847 consecutive biopsies)
Watlter  Adriano bianchini  (2003)  in  his  study  found the  undifferentiated 
cancers constitutes 1.1%  of all tumors diagnosed 43 cases out of 3,840.
Sex Incidence
There were 20 male (66%) , 10 female(33%) cases in a proportion of 
2:1 was found in this study 
which was supported by AlbinaMaria Albermani in his study. Male 
and female ratio is 67.5% and female  is 32.5%. Head and Neck cancers 
found predominantly in males than in females. Indian text books describe 
that most of the head and neck cancer ocurs predominantly in males.
 Age Incidence
Head  and Neck cancers and undifferentiated head and neck cancers 
were found predominantly in males.
Patients age ranged from 17 years to 72 years 
These  tumors  were  most  prevalent  in  6th decade  of  life(30%) 
followed by 4th decade of life(23%)
Robert.J.Carpenter in his study (1989) found that in head and neck 
cancers, 60% of his patients in 5th and 6th decade
 Walter adriano bianchini and Jarge Rizzato Paschaal (2003) in their 
study, the prevalence rate of undifferentiated carcinoma is in the 7th decade 
of life(34.9%)
Age of the patient ranged from 2 years to 89 years.
Incidence of site of undifferentiated cancer
Abemayor.E;  Kessler  DJ,  Ward  PH  (1987)  in  their  study  the 
commonest  site  of  occurrence of  head and neck tumor  was pharynx and 
neck(21%) , lymphnode(18%), paranasal sinus(14%)
Walter Adriano bianchini (2003) in their study the commonest site of 
occurrence in Lymphnode (20.9%), pharynx(16.3%), Nose(11.6%) and PNS 
(9%)
In  this  study  highest  incidence  was  in  Oropharynx   (23%), 
Nasopharynx  (20%) followed  by  Nose  and  paranasal  sinuses  (20%), 
hypopharynx(13%) 
Proportional incidence of the undifferentiated cancer
When  compared  to  the  other  tumor  types  of  the  same  site,  the 
proportion of undifferentiated head  and neck cancer is as follows.
Nasopharynx(23%),  Paranasal  sinus(15.8%),  nose(14%). These 
data was supported by Gallo.O. Graziani et al (1993) – Nasopharynx(18%), 
Paranasal sinus(21%), nose (18%).
Subsite  wise  the more  number  of  undifferentiated  tumors  found in 
posterior 1/3 of   a tongue  and nasopharynx.(six  patients)
Type of tumors diagnosed by Immunohistochemical methods
The  immunohistochemical  technique  was  usseful  in  conclusive 
diagnosis of the tumors in the oral cavity (100%), nasopharynx(100%), nose 
and nasopharynx(100%).
Milroy  CM.  Ferlito  A  et  al  (1995)  in  his  study  ,  the  conclusive 
diagnosis  was  as  follows  :  oral  cavity(100%),  Paranasal  sinus(100%), 
Lymphnodes(89.9%) and Nasopharynx(57%).
Galter et al  (1985) and  Coindre et  al  (1982) demonstrated greater 
incidence of lymphomas in undifferentiatied tumors in general.
Darrouzet .V et al (1989) in his  study , the most frequent tumor is 
carcinoma(39%)
Walter Adriano Bianchini et al(2003) in his study , the most frequent 
tumor is carcinoma(27.9%)  followed  by lymphoma(20.93%)
In  this  study,  the  commonest  tumor  type  diagnosed  is  carcinoma 
(43%) followed by lymphoma (23%)
Lymphoma was commonly found in the patients below the age of 30 
years (4 cases ) -57%.
Carcinoma found in patients above 40 years of age (10 to 15 cases)
 – 76.92%.
Lymphomas  commonly  found  in  the  oropharynx(Tonsil)  and 
Nasopharynx, except 1 case, all are B cell Lymphoma.
Sensitivity  of the Immunohistochemistry
Abemayor et al (1987) in his study using immunohistochemistry, the 
conclusive diagnosis was achieved in 86.4% patients. It was not possible in 
13.6%.
Walter  Adriano  Bianchini  et  al  (2003)  in  his  study,  using 
immunohistochemistry, the diagnostic guidance was obtained in 81.4% of 
patients(35 of 43). It was not possible in 18.6%( 8 of 43)
In this study, conclusive diagnosis obtained in 80% (24 of 30) of the 
patient. The result was inconclusive in 6 of 30 patients (20%)
The  failure  is  probably  due  to  limitations  of  the  technique,  lesser 
number of immunohistochemical panel of markers, Antigen changes during 
tissue fixation, true absence of cellular differentiation.
Immunohistochemical Markers (Panels)
Gallo .O et al (1993) used 19 immunohistochemical markers as panel 
to study the undifferentiated cancer of nose and paranasal sinuses.
Walter Adriano et al (2003) used about 23 panel of immunohistochemical 
markers.
In  this  study,  5  immunohistochemical  markers  was  used. 
Cytokeratin positive cancers is the common pattern. 18 of 30 (60%), CD3 (8 
of 30),CD45 (7 of 30), S-100(3 of 30).
Most of the head and neck tumors are of epithelial in origin, 
CONCLUSIONS
1. Undifferentiated cancers   in the head and neck represents 
3.57% of all tumors diagnosed in this study.
2. Undifferentiated  head  and  neck  cancers  found 
predominantly  in  the  males  (66%)  and  highest  incidence 
after the 4th decade of life (68%).
3. Undifferentiated  head  and  neck  cancers  most  frequently 
occurs  in the nasopharynx (23%), nose (14%) and paranasal 
sinuses(16%) in this study.
4. Immunohistochemical  tehcnique  is  sensitive  enough  to 
conclusively diagnose 80% of the undifferentiated head and 
neck cancer.
5. The most  common  tumor  type  diagnosed  in  this  study  is 
carcinoma(43%) followed by lymphoma(23%)
6. 100%  conclusive  diagnosis  achieved  in  oral  cavity, 
Nasopharynx and Sinonasal cancers
This  study  supports  the  notion  that  the  immunohistochemical 
technique has a fundamental role in the investigation and definition of 
undifferentiated tumor origin,  thus determining  correct  guidance for 
treatment  and  possibly  improving  the  prognosis  for  head  and  neck 
oncological patients. 
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